Double Rainbow Announces Membership with BioMADE

20 Oct 2022

  IMG 0570 1
  • Sustainable biotech company joins a team of U.S. government, industry and academic leaders dedicated to innovation in biomanufacturing
  • The membership comes as the Biden Administration recently unveiled a $2 billion pledge to expand biomanufacturing and biotechnology

Lexington, Mass. – October 20, 2022, — Double Rainbow, a sustainable health care company harnessing the power of natural evolution through bioengineering to improve the quality of human health, today announced its membership with BioMADE. A leading organization in the biotech space, BioMADE reduces barriers to scale-up and commer­cial­iza­tion, accelerates technology deployment to create disruptive business models, and re-develops existing biotechnology to enhance national competitiveness.

Double Rainbow’s membership opens a variety of opportunities for the organization, including access to a wealth of industry research and project funding, governance and policy development, education and workforce growth, and much more.

BioMADE’s values go hand in hand with Double Rainbow’s, which makes this the perfect partnership. We both place a premium on sustainability, innovation, education and collaboration,” said Jing-Ke Weng, Ph.D., Co-founder of Double Rainbow. Membership will strengthen our already robust initiatives in genomics, metabolomics and synthetic biology. We look forward to collaborating with BioMADE and are fully aligned with its goals to advance the future of biotech.”

Membership will strengthen our already robust initiatives in genomics, metabolomics and synthetic biology. We look forward to collaborating with BioMADE and are fully aligned with its goals to advance the future of biotech.
Jing-Ke Weng, Ph.D., Co-founder of Double Rainbow

BioMADE enables domestic bioindustrial manufacturing at all scales, develops technologies to enhance U.S. bioindustrial competitiveness, de-risks investment in relevant infrastructure, and expands the biomanufacturing workforce to realize the economic promise of the industry.

Double Rainbow’s membership comes as the Biden Administration recently unveiled a $2 billion pledge to expand biomanufacturing and biotechnology through a variety of efforts. Consistent with the goals of the newly signed Executive Order, BioMADE has announced a suite of projects that will collectively help secure America’s future through bioindustrial manufacturing innovation, education, and collaboration. The projects will lead to the creation of new biomanufactured products, development of best practices, assistance with vaccine component production, and growth of the bioindustrial manufacturing workforce.

About BioMADE


Launched in 2021, BioMADE is a Manufacturing Innovation Institute sponsored by the U.S. Department of Defense. It is also a member of Manufacturing USA®, a national network created to secure U.S. global leadership in advanced manufacturing through large-scale public-private collaboration on technology, supply chain, and education and workforce development. Learn more at biomade.org.

About Double Rainbow


Double Rainbow is a sustainable biotech company harnessing the power of natural evolution through bioengineering to improve the quality of human health and ensure the sustainability of our planet. By leveraging advances in the areas of genomics, metabolomics, and synthetic biology, we are accessing the richness and efficacy of natural chemistry like never before to bring therapeutics and bioceuticals to the world at scale without harming the environment. Learn more at www.doublerainbowbio.com.

Related News